These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of the chloride channel activator lubiprostone for constipation in adults with cystic fibrosis: a case series. O'Brien CE; Anderson PJ; Stowe CD Ann Pharmacother; 2010 Mar; 44(3):577-81. PubMed ID: 20179256 [TBL] [Abstract][Full Text] [Related]
9. Lubiprostone for constipation in adults with cystic fibrosis: a pilot study. O'Brien CE; Anderson PJ; Stowe CD Ann Pharmacother; 2011 Sep; 45(9):1061-6. PubMed ID: 21852592 [TBL] [Abstract][Full Text] [Related]
11. Lubiprostone: a novel treatment for chronic constipation. Lacy BE; Levy LC Clin Interv Aging; 2008; 3(2):357-64. PubMed ID: 18686757 [TBL] [Abstract][Full Text] [Related]
12. Lubiprostone: a new drug for the treatment of chronic idiopathic constipation. Baker DE Rev Gastroenterol Disord; 2007; 7(4):214-22. PubMed ID: 18192957 [TBL] [Abstract][Full Text] [Related]
16. Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome. Chamberlain SM; Rao SS Expert Opin Drug Saf; 2012 Sep; 11(5):841-50. PubMed ID: 22834474 [TBL] [Abstract][Full Text] [Related]
17. Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome. Schey R; Rao SS Dig Dis Sci; 2011 Jun; 56(6):1619-25. PubMed ID: 21523369 [TBL] [Abstract][Full Text] [Related]
18. Chloride transporting capability of Calu-3 epithelia following persistent knockdown of the cystic fibrosis transmembrane conductance regulator, CFTR. MacVinish LJ; Cope G; Ropenga A; Cuthbert AW Br J Pharmacol; 2007 Apr; 150(8):1055-65. PubMed ID: 17339840 [TBL] [Abstract][Full Text] [Related]
19. Lubiprostone prevents nonsteroidal anti-inflammatory drug-induced small intestinal damage by suppressing the expression of inflammatory mediators via EP4 receptors. Hayashi S; Kurata N; Yamaguchi A; Amagase K; Takeuchi K J Pharmacol Exp Ther; 2014 Jun; 349(3):470-9. PubMed ID: 24713141 [TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology of lubiprostone, a chloride channel activator in defecation disorders. Ginzburg R; Ambizas EM Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1091-7. PubMed ID: 18680443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]